98 related articles for article (PubMed ID: 18633939)
1. The application of perfluorooctanoate to investigate trimerization of the human immunodeficiency virus-1 gp41 ectodomain by electrophoresis.
Lin CH; Chang CC; Cheng SF; Chang DK
Electrophoresis; 2008 Aug; 29(15):3175-82. PubMed ID: 18633939
[TBL] [Abstract][Full Text] [Related]
2. Trimerization specificity in HIV-1 gp41: analysis with a GCN4 leucine zipper model.
Shu W; Ji H; Lu M
Biochemistry; 1999 Apr; 38(17):5378-85. PubMed ID: 10220324
[TBL] [Abstract][Full Text] [Related]
3. The extracellular domain of immunodeficiency virus gp41 protein: expression in Escherichia coli, purification, and crystallization.
Wingfield PT; Stahl SJ; Kaufman J; Zlotnick A; Hyde CC; Gronenborn AM; Clore GM
Protein Sci; 1997 Aug; 6(8):1653-60. PubMed ID: 9260278
[TBL] [Abstract][Full Text] [Related]
4. An efficient production and characterization of HIV-1 gp41 ectodomain with fusion peptide in Escherichia coli system.
Lin CH; Lin CH; Chang CC; Wei TS; Cheng SF; Chen SS; Chang DK
J Biotechnol; 2011 Apr; 153(1-2):48-55. PubMed ID: 21419812
[TBL] [Abstract][Full Text] [Related]
5. Functional solubilization of aggregation-prone HIV envelope proteins by covalent fusion with chaperone modules.
Scholz C; Schaarschmidt P; Engel AM; Andres H; Schmitt U; Faatz E; Balbach J; Schmid FX
J Mol Biol; 2005 Feb; 345(5):1229-41. PubMed ID: 15644217
[TBL] [Abstract][Full Text] [Related]
6. Conformational stability and membrane interaction of the full-length ectodomain of HIV-1 gp41: implication for mode of action.
Lev N; Fridmann-Sirkis Y; Blank L; Bitler A; Epand RF; Epand RM; Shai Y
Biochemistry; 2009 Apr; 48(14):3166-75. PubMed ID: 19206186
[TBL] [Abstract][Full Text] [Related]
7. Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor.
Deng Y; Zheng Q; Ketas TJ; Moore JP; Lu M
Biochemistry; 2007 Apr; 46(14):4360-9. PubMed ID: 17371053
[TBL] [Abstract][Full Text] [Related]
8. The role of the N-terminal heptad repeat of HIV-1 in the actual lipid mixing step as revealed by its substitution with distant coiled coils.
Wexler-Cohen Y; Sackett K; Shai Y
Biochemistry; 2005 Apr; 44(15):5853-61. PubMed ID: 15823044
[TBL] [Abstract][Full Text] [Related]
9. An alternative conformation of the gp41 heptad repeat 1 region coiled coil exists in the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor.
Mische CC; Yuan W; Strack B; Craig S; Farzan M; Sodroski J
Virology; 2005 Jul; 338(1):133-43. PubMed ID: 15950253
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 gp41 tertiary structure studied by EPR spectroscopy.
Rabenstein MD; Shin YK
Biochemistry; 1996 Nov; 35(44):13922-8. PubMed ID: 8909289
[TBL] [Abstract][Full Text] [Related]
11. Improved separation of integral membrane proteins by continuous elution electrophoresis with simultaneous detergent exchange: application to the purification of the fusion protein of the human immunodeficiency virus type 1.
Viard M; Blumenthal R; Raviv Y
Electrophoresis; 2002 Jun; 23(11):1659-66. PubMed ID: 12179985
[TBL] [Abstract][Full Text] [Related]
12. Membrane-transferring sequences of the HIV-1 Gp41 ectodomain assemble into an immunogenic complex.
Lorizate M; Gómara MJ; de la Torre BG; Andreu D; Nieva JL
J Mol Biol; 2006 Jun; 360(1):45-55. PubMed ID: 16813835
[TBL] [Abstract][Full Text] [Related]
13. Expression and biochemical analysis of the entire HIV-2 gp41 ectodomain: determinants of stability map to N- and C-terminal sequences outside the 6-helix bundle core.
Lay CS; Wilson KA; Kobe B; Kemp BE; Drummer HE; Poumbourios P
FEBS Lett; 2004 Jun; 567(2-3):183-8. PubMed ID: 15178320
[TBL] [Abstract][Full Text] [Related]
14. Role of the specific amino acid sequence of the membrane-spanning domain of human immunodeficiency virus type 1 in membrane fusion.
Miyauchi K; Komano J; Yokomaku Y; Sugiura W; Yamamoto N; Matsuda Z
J Virol; 2005 Apr; 79(8):4720-9. PubMed ID: 15795258
[TBL] [Abstract][Full Text] [Related]
15. A template-assembled model of the N-peptide helix bundle from HIV-1 Gp-41 with high affinity for C-peptide.
Xu W; Taylor JW
Chem Biol Drug Des; 2007 Oct; 70(4):319-28. PubMed ID: 17937777
[TBL] [Abstract][Full Text] [Related]
16. Interactions between HIV-1 gp41 core and detergents and their implications for membrane fusion.
Shu W; Ji H; Lu M
J Biol Chem; 2000 Jan; 275(3):1839-45. PubMed ID: 10636883
[TBL] [Abstract][Full Text] [Related]
17. Role of the extracellular loop in the folding of a CFTR transmembrane helical hairpin.
Wehbi H; Rath A; Glibowicka M; Deber CM
Biochemistry; 2007 Jun; 46(24):7099-106. PubMed ID: 17516627
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody.
Luftig MA; Mattu M; Di Giovine P; Geleziunas R; Hrin R; Barbato G; Bianchi E; Miller MD; Pessi A; Carfí A
Nat Struct Mol Biol; 2006 Aug; 13(8):740-7. PubMed ID: 16862157
[TBL] [Abstract][Full Text] [Related]
19. [High level expression of 5-helix protein in HIV gp41 heptad repeat regions and its virus fusion-inhibiting activity].
Wang J; Pan X; Tien P; Liu S
Sheng Wu Gong Cheng Xue Bao; 2009 Mar; 25(3):435-40. PubMed ID: 19621587
[TBL] [Abstract][Full Text] [Related]
20. Recombinant fusion proteins for the industrial production of disulfide bridge containing peptides: purification, oxidation without concatamer formation, and selective cleavage.
Döbeli H; Andres H; Breyer N; Draeger N; Sizmann D; Zuber MT; Weinert B; Wipf B
Protein Expr Purif; 1998 Apr; 12(3):404-14. PubMed ID: 9535709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
